Back
Bicara Therapeutics Vs. Strategy Industry Stock Comparison
Buy
55
BCAX
Bicara Therapeutics
Last Price:
$12.45
Seasonality Move:
--
Buy
52
MSTR
Strategy
Last Price:
$283.26
Seasonality Move:
-5.49%
Buy
55
Bicara Therapeutics (BCAX)
is a Buy
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $13.50. The Score for BCAX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
BCAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $13.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 49.06 | Sell |
Chaikin Money Flow: | 387051 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.34 - 14.42) | Buy |
Bollinger Bands (100): | (12.93 - 21.21) | Sell |
MSTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -12.38 | Sell |
Relative Strength Index (14 RSI): | 50.53 | Buy |
Chaikin Money Flow: | 8661825 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (264.27 - 326.63) | Sell |
Bollinger Bands (100): | (266.3 - 382.96) | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.25 | Sell |
20-day SMA: | 13.52 | Sell |
50-day SMA: | 13.44 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 13.61 | Sell |
20-day EMA: | 13.57 | Sell |
50-day EMA: | 14.04 | Sell |
200-day EMA: | 11.16 | Buy |
MSTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 284.75 | Buy |
20-day SMA: | 287.61 | Buy |
50-day SMA: | 320.37 | Sell |
200-day SMA: | 237.74 | Buy |
8-day EMA: | 282.26 | Buy |
20-day EMA: | 290.16 | Buy |
50-day EMA: | 308.43 | Sell |
200-day EMA: | 252.4 | Buy |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and a decrease next year of $0.54 per share.
Strategy Earnings Growth & MSTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $37.64 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.
Bicara Therapeutics Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Strategy Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |